Canada's Kits Eyecare Q2 revenue slightly misses estimates

Kits Eyecare

09/07/2026 12:08

Overview
Canada eyecare provider's preliminary Q2 revenue rose 17% yr/yr, slightly missing analyst expectations
Preliminary Q2 glasses revenue grew 51% yr/yr to about C$10.8 mln
Adjusted EBITDA exceeded 4.5% of revenue; cash balance surpassed C$27.3 mln, no debt

Outlook
Company did not provide specific guidance for the current or upcoming periods in the press release

Result Drivers
GLASSES SEGMENT GROWTH - Glasses revenue expanded 51% yr/yr to about C$10.8 mln
CASH GENERATION - Strong cash generation in the quarter drove the Companys cash balance to exceed $27.3 million, and no debt

Company press release: ID:nCNWd4Fhba

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Slight Miss*
C$58.20 mln
C$58.22 mln (5 Analysts)
*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy"
Wall Street's median 12-month price target for Kits Eyecare Ltd is C$22.00, about 56.4% above its July 8 closing price of C$14.07
The stock recently traded at 47 times the next 12-month earnings vs. a P/E of 52 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)